Neoadjuvant Treatment in Resectable Pancreatic Cancer

NCT01900327 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

32

Enrollment

OTHER

Sponsor class

Stopped Recruitment failure

Conditions

Pancreatic Cancer

Interventions

RADIATION: External Beam Radiation
DRUG: Gemcitabine neoadjuvant
PROCEDURE: Surgery
DRUG: Gemcitabine adjuvant

Sponsor

Universitätsklinikum Hamburg-Eppendorf

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]